Published in Health Business Week, December 9th, 2005
This quarter's growth rate includes an estimated 2% benefit from foreign currency translation. Revenue growth in all segments benefited from foreign currency translation, driven primarily by favorable exchange rates in Latin America, Asia Pacific, and Canada.
"Our excellent results this year were driven, in particular, by our strong international performance, new product revenue growth, and significant margin improvement," said Edward J. Ludwig,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week